Advertisement

Breast Cancer Research and Treatment

, Volume 35, Issue 1, pp 51–60 | Cite as

The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology

  • Beth Newman
  • Patricia G. Moorman
  • Robert Millikan
  • Bahjat F. Qaqish
  • Joseph Geradts
  • Tim E. Aldrich
  • Edison T. Liu
Article

Summary

The integration of epidemiology and molecular biology provides a new strategy to identify additional risk factors for breast cancer and to better understand the role played by traditionally recognized risk factors. The Carolina Breast Cancer Study (CBCS) is a population-based, case-control study designed to identify causes of breast cancer among Caucasian and African-American women who are residents of a 24-county area of central and eastern North Carolina. Information on established and potential breast cancer risk factors is obtained by personal interviews. Blood samples are collected from all consenting participants. Medical record documentation and paraffin-embedded tumor specimens are obtained for all breast cancer patients. DNA from tumor tissue is tested for a variety of molecular alterations characteristic of breast cancer. Germline DNA from blood lymphocytes is evaluated for presence of alleles increasing susceptibility to breast cancer. Statistical analyses evaluate gene-environment interaction by exploring the associations between environmental/behavioral factors and breast cancer in relation to specific molecular alterations (germline and tumor). Results will help identify high-risk women, clarify causal pathways, and hopefully contribute to the prevention of breast cancer.

Key words

breast cancer etiology gene-environment interactions genetic susceptibility molecular epidemiology risk factors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lane-Claypon JE: A further report on cancer of the breasts, with special reference to its associated antecedent conditions. Reports of the Ministry of Health, No. 32, 1926Google Scholar
  2. 2.
    Kelsey JL (ed): Breast cancer. Epidemiol Rev 15:1–263, 1993Google Scholar
  3. 3.
    Harris JR, Lippman ME, Veronesi U, Willett W: Breast cancer (first of three parts). N Engl J Med 327:319–328, 1992Google Scholar
  4. 4.
    Seidman H, Stellman SD, Mushinski MH: A different perspective on breast cancer risk factors: Some implications of nonattributable risk. CA-A Cancer Journal for Clinicians 32:301–313, 1982Google Scholar
  5. 5.
    Weiss N, Liff J: Accounting for the multicausal nature of disease in the design and analysis of epidemiologic studies. Am J Epidemiol 117:14–18, 1983Google Scholar
  6. 6.
    Harris JR, Lippman ME, Veronesi U, Willett W: Breast cancer (second of three parts). N Engl J Med 327:390–398, 1992Google Scholar
  7. 7.
    Stanford JL, Szklo M, Brinton LA: Estrogen receptors and breast cancer. Epidemiol Rev 8:42–59, 1986Google Scholar
  8. 8.
    Habel LA, Stanford JL: Hormone receptors and breast cancer. Epidemiol Rev 15:209–219, 1993Google Scholar
  9. 9.
    Bassett MT, Krieger N: Social class and black-white differences in breast cancer survival. Am J Public Health 76:1400–1403, 1986Google Scholar
  10. 10.
    Coates RJ, Clark WS, Eley JW, Greenberg RS, Huguley CM, Brown RL: Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 82: 1684–1692, 1990Google Scholar
  11. 11.
    Natarajan N, Nemoto T, Mettlin C, Murphy GP: Racerelated differences in breast cancer patients. Cancer 56:1704–1709, 1985Google Scholar
  12. 12.
    Kelsey JL, Horn-Ross PL: Breast cancer: Magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7–16, 1993Google Scholar
  13. 13.
    Newman B, Austin MA, Lee M, King M-C: Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044–3048, 1988Google Scholar
  14. 14.
    Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232–242, 1991Google Scholar
  15. 15.
    Hall J, Lee M, Newman B, Morrow J, Huey B, King M-C: Linkage of early onset familial breast cancer to chromosome 17q21. Science 250:1684–1689, 1990Google Scholar
  16. 16.
    Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM: Familial breast-ovarian cancer locus on chromosome 17q12–q23. Lancet 338: 82–83, 1991Google Scholar
  17. 17.
    King M-C, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975–1980, 1993Google Scholar
  18. 18.
    Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King M-C, Egilsson V, Devilee P, McManus R, Daly PA, Smyth E, Ponder BAJ, Peto J, Cannon-Albright L, Easton DF, Goldgar DE: Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genet 7:103–107, 1994Google Scholar
  19. 19.
    Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238, 1990Google Scholar
  20. 20.
    Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N: Inherited p53 gene mutations in breast cancer. Cancer Res 52:2984–2986, 1992Google Scholar
  21. 21.
    Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King M-C: Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 48:1065–1068, 1991Google Scholar
  22. 22.
    Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ, Stratton MR: A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2:132–134, 1992Google Scholar
  23. 23.
    Lobaccaro J-M, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron J-F, Pujol H, Sultan C: Male breast cancer and the androgen receptor gene. Nature Genet 5:109–110, 1993Google Scholar
  24. 24.
    Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N: An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 329:517–523, 1993Google Scholar
  25. 25.
    Garrett PA, Hulka BS, Kim YL, Farber RA. HRAS protooncogene polymorphism and breast cancer. Cancer Epidemiol Biomarkers Prev 2:131–138, 1993Google Scholar
  26. 26.
    Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene,BRCA2, to chromosome 13q12–13. Science 265:2088–2090, 1994Google Scholar
  27. 27.
    Van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesoi O, Nusse R: Neu protein overexpression in breast cancer: Association with comedotype ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 391: 1239–1245, 1988Google Scholar
  28. 28.
    Liu E, Thor A, He M, Barcos M, Ljung B-M, Benz C: The HER2 (c-erbB-2) oncogene is frequently amplified inin situ carcinomas of the breast. Oncogene 7:1027–1032, 1992Google Scholar
  29. 29.
    Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO: p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol 24:463–468, 1993Google Scholar
  30. 30.
    Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR: IncreasederbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 50:6701–6707, 1990Google Scholar
  31. 31.
    Bartkova J, Bartek J, Vojtesek B, Lukas J, Rejthar A, Kovarik J, Millis RR, Lane EP, Barnes DM: Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours. Eur J Cancer 29A:881–886, 1993Google Scholar
  32. 32.
    Weinberg CR, Wacholder S: The design and analysis of case-control studies with biased sampling. Biometrics 46:963–975, 1990Google Scholar
  33. 33.
    Weinberg CR, Sandler DP: Randomized recruitment in case-control studies. Am J Epidemiol 134:421–432, 1991Google Scholar
  34. 34.
    Van de Vijver MJ, Nusse R: The molecular biology of breast cancer. Biochim Biophys Acta 1072:33–50, 1991Google Scholar
  35. 35.
    Callahan R, Cropp CS, Merlo GR, Liscia DS, Cappa APM, Lidereau R: Somatic mutations and human breast cancer: A status report. Cancer 69:1582–1588, 1992Google Scholar
  36. 36.
    Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM: Identification and cloning of two overexpressed genes, U21B31/PRAD1 andEMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355–361, 1992Google Scholar
  37. 37.
    Harris AL: p53 expression in human breast cancer. Adv Cancer Res 59:69–88, 1992Google Scholar
  38. 38.
    Blaszyk H, Baughn CB, Hartmann A, McGovern RM, Schroeder JJ, Cunningham J, Schaid D, Sommer SS, Kovach JS: Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet 343:1195–1197, 1994Google Scholar
  39. 39.
    Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678–701, 1993Google Scholar
  40. 40.
    Thompson WD: Statistical analysis of case-control studies. Epidemiol Rev 16:33–50, 1994Google Scholar
  41. 41.
    Olsson H, Borg A, Ferno M, Ranstam J, Sigurdsson H: Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. J Natl Cancer Inst 83:1483–1487, 1991Google Scholar
  42. 42.
    Treurniet HF, Rookus MA, Peterse HL, Hart AAM, van Leeuwen FE: Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor. Cancer Res 52:2344–2345, 1992Google Scholar
  43. 43.
    Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 15:36–47, 1993Google Scholar
  44. 44.
    Feuer EJ, Wun L-M, Boring CC, Flanders WD, Timmel MJ, Tong T: The lifetime risk of developing breast cancer. J Natl Cancer Inst 85:892–897, 1993Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Beth Newman
    • 1
    • 2
  • Patricia G. Moorman
    • 1
    • 2
  • Robert Millikan
    • 1
    • 2
  • Bahjat F. Qaqish
    • 2
    • 3
  • Joseph Geradts
    • 2
    • 4
  • Tim E. Aldrich
    • 1
    • 2
    • 5
  • Edison T. Liu
    • 1
    • 2
    • 6
  1. 1.Department of Epidemiology, CB#7400 McGavran-Greenberg Hall, School of Public HealthUniversity of North CarolinaUSA
  2. 2.Lineberger Comprehensive Cancer CenterUniversity of North CarolinaUSA
  3. 3.Department of Biostatistics, School of Public HealthUniversity of North CarolinaUSA
  4. 4.Department of Pathology, School of MedicineUniversity of North CarolinaUSA
  5. 5.North Carolina Central Cancer Registry, Department of EnvironmentHealth and Natural ResourcesRaleighUSA
  6. 6.Department of Medicine, School of MedicineUniversity of North CarolinaUSA

Personalised recommendations